These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28069650)

  • 21. The effect of statins on mortality in patients with bacteremia.
    Liappis AP; Kan VL; Rochester CG; Simon GL
    Clin Infect Dis; 2001 Oct; 33(8):1352-7. PubMed ID: 11565076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.
    Smith JR; Frens JJ; Snider CB; Claeys KC
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):50-54. PubMed ID: 29153470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity in the treatment of bloodstream infections identified from antibiotic exposure mapping.
    Caffrey AR; Babcock ZR; Lopes VV; Timbrook TT; LaPlante KL
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):707-715. PubMed ID: 30916833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
    Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY
    J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proactive infectious disease consultation at the time of blood culture collection is associated with decreased mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia: A retrospective cohort study.
    Kawasuji H; Sakamaki I; Kawamura T; Ueno A; Miyajima Y; Matsumoto K; Kawago K; Higashi Y; Yamamoto Y
    J Infect Chemother; 2020 Jun; 26(6):588-595. PubMed ID: 32085966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study.
    Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Sakoulas G; Perencevich EN
    PLoS One; 2010 Jul; 5(7):e11432. PubMed ID: 20625395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
    Shurland S; Zhan M; Bradham DD; Roghmann MC
    Infect Control Hosp Epidemiol; 2007 Mar; 28(3):273-9. PubMed ID: 17326017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
    Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M;
    Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
    Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of delayed appropriate antimicrobial therapy on children with Staphylococcus aureus blood infection.
    Guo Z; Xu X; Zhang G; Wang X; Tian X; Li Y; Li Q; Chen D; Luo Z
    Eur J Pediatr; 2024 Sep; 183(9):3785-3796. PubMed ID: 38874791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of antimicrobial regimen on decreased in-hospital mortality of patients with MRSA bacteremia.
    Kaku N; Yanagihara K; Morinaga Y; Yamada K; Harada Y; Migiyama Y; Nagaoka K; Matsuda J; Uno N; Hasegawa H; Miyazaki T; Izumikawa K; Kakeya H; Yamamoto Y; Kohno S
    J Infect Chemother; 2014 Jun; 20(6):350-5. PubMed ID: 24731430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High vancomycin minimum inhibitory concentration is associated with poor outcome in patients with methicillin-susceptible Staphylococcus aureus bacteremia regardless of treatment.
    Castón JJ; González-Gasca F; Porras L; Illescas S; Romero MD; Gijón J
    Scand J Infect Dis; 2014 Nov; 46(11):783-6. PubMed ID: 25134647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss.
    Herzke CA; Chen LF; Anderson DJ; Choi Y; Sexton DJ; Kaye KS
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1057-61. PubMed ID: 19803766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.
    Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A
    Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.
    Mohanty A; Tate JP; Garcia-Tsao G
    Gastroenterology; 2016 Feb; 150(2):430-40.e1. PubMed ID: 26484707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statin Use and Hospital Length of Stay Among Adults Hospitalized With Community-acquired Pneumonia.
    Havers F; Bramley AM; Finelli L; Reed C; Self WH; Trabue C; Fakhran S; Balk R; Courtney DM; Girard TD; Anderson EJ; Grijalva CG; Edwards KM; Wunderink RG; Jain S
    Clin Infect Dis; 2016 Jun; 62(12):1471-1478. PubMed ID: 27169476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of outcome and clinical characteristics of bacteremia caused by methicillin-resistant, penicillin-resistant and penicillin-susceptible Staphylococcus aureus strains.
    Jokinen E; Laine J; Huttunen R; Rahikka P; Huhtala H; Vuento R; Vuopio J; Syrjänen J
    Infect Dis (Lond); 2017 Jul; 49(7):493-500. PubMed ID: 28276799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timing of initiating glycopeptide therapy for methicillin-Resistant Staphylococcus aureus bacteremia: the impact on clinical outcome.
    Lee CH; Chien CC; Liu JW
    ScientificWorldJournal; 2013; 2013():457435. PubMed ID: 23401670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
    Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
    Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.